Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jiangsu Jiangshan Juyuan Biotechnology

Request full access

Jiangsu Jland Biotech Co., Ltd produces non-animal derived collagen for cosmetics, research and medical applications

ChinaFounded 2006Biotech & Life Sciences

About Jiangsu Jiangshan Juyuan Biotechnology

Jiangsu Jiangshan Juyuan Biotechnology (Jland Biotech), established in 2015, operates as a specialized developer and producer of recombinant collagen, positioning itself as a key player in the biotechnology sector. The company was co-founded by the Aland Group, a global nutrition provider, in collaboration with Professor Yang Shulin's team, who invented the recombinant human collagen (RHC) technology, and the Nanjing University of Science and Technology. This strategic foundation has enabled Jland Biotech to focus on the entire value chain, from research and development to the production and application of recombinant collagen proteins. In November 2023, the company's growth trajectory was highlighted by its selection as a potential unicorn enterprise in Jiangsu Province.

Jland Biotech's business model encompasses a vertically integrated approach, covering the full industrial chain from gene design and strain construction to large-scale production and downstream application development. The company generates revenue through three primary channels: the sale of recombinant protein raw materials, providing Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services for cosmetic brands, and marketing its own branded products. This structure allows Jland to serve a diverse client base, including over 300 global brands and factories, such as Proya, OSM, and Hongxing Erke. A significant partnership was formed with Germany-based Evonik, which not only invested in Jland through its venture capital arm but also collaborates on marketing Jland's vegan collagen for various skincare applications.

The core of Jland Biotech's offering is its recombinant human-like collagen, branded as Biollagen™, produced via a patented fermentation process using Pichia pastoris yeast. This method creates a pure, animal-free product, addressing the growing demand for vegan and ethically sourced cosmetic ingredients. The company's product portfolio is extensive, including various types of recombinant collagen (Type I, III, IV, V, XVII), fibronectin, and elastin. These proteins are formulated into raw materials for other manufacturers or used in Jland's own finished products, such as freeze-dried repair series, active glass series, and anti-wrinkle skincare lines. A key feature is the company's advanced production capability, which can yield 20 tons of high-purity recombinant collagen powder annually, and its use of AI-driven freeze-drying technology to preserve product efficacy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
8
Open positions
None listed
Dealroom signal
44.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC May 2025 $14M $55M SDIC Fund Management · Yuexiu Industrial Fund ↗
SERIES B✓Equity / VC Sep 2023 $0 — Evonik Venture Capital · Cenova Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Jiangsu Jiangshan Juyuan Biotechnology website traffic

Latest recorded traffic for Jiangsu Jiangshan Juyuan Biotechnology is 220 monthly website visits, up 1000% over the last three months. Jiangsu Jiangshan Juyuan Biotechnology's team grew 60% over the past year.

Latest monthly visits220 3-month web change+1000% 1-year team growth+60%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Jiangsu Jiangshan Juyuan Biotechnology in its local ecosystem

Live from Dealroom

The Jiangsu Jiangshan Juyuan Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Evonik Venture Capital
  • Cenova Capital

Series B and later2 investors entered at this stage

  • SDIC Fund Management
  • Yuexiu Industrial Fund

Other known investors2 additional known investors

  • Jiangnan University
  • Nanjing University of Science and Technology
Employees 8 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇬🇧 United Kingdom50%
🇭🇰 Hong Kong25%
🇨🇳 China25%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jiangsu Jiangshan Juyuan Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jiangsu Jiangshan Juyuan Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.